STAT+: Dear Vinay: Please embrace dissent and fade into the background
Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the key to his success.
Previous Post
Policy Tracker: Youth Access to Gender Affirming Care and State Policy Restrictions
Next Post
Data Show Disparities in HMA Use Among Myelodysplastic Syndrome Populations
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago